Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Oct 28 - Nov 2
This represents the first FDA-approved oral GLP-1 medication for weight management
29 The randomized, double-blind study enrolled 1,864 participants with a mean baseline A1C of 8.3% and BMI of 32.5
Typical Candidate Profile: BMI of 30 or higher (obese), or BMI of 27+ with at least one weight-related condition (hypertension, type 2 diabetes, high cholesterol) Have not achieved significant results with diet and exercise alone Looking for a medically supervised weight loss approach No contraindications such as personal or family history of medullary thyroid carcinoma or MEN2 The LightRx Process: 1
Detection: 220 nm (peptide) and 650 nm (Cu complex)
One AssuredPartners case study found GLP1 users saved about $560 per person per year in medical costs but against an average annual drug cost of $6,540, the nearterm ROI is negative for most employers
US$ 27.39
US$ 27.49
US$ 26.92
